Bone loss (osteopenia) in old male mice results from diminished activity and availability of TGF-β

Journal of Cellular Biochemistry

Volumn 70, Issue 4, 1998, Pages 478-488

  Gazit, Dan ^a   Zilberman, Yoram ^a   Ebner, Reinhard ^b   Kahn, Arnold ^c,d  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b GLAXOSMITHKLINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Bone formation; Growth factors; Osteopenia; Osteoporosis

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

AGING; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CELL PROLIFERATION; CONTROLLED STUDY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; STEM CELL;

AGING; ANIMALS; BONE DEVELOPMENT; BONE DISEASES, METABOLIC; BONE MARROW CELLS; MALE; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA; MAMMALIA;

EID: 0032531278     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19980915)70:4<478::AID-JCB5>3.0.CO;2-G     Document Type: Article

References (55)

1. Aspenberg P, Jeppson C, Wang JS, Bostorm M (1996): Transforming growth factor beta and bone morphogenetic protein 2 for bone ingrowth: A comparison using bone chambers in rats. Bone 19: 499-503.
2. Baron JA, Karagas M, Barrett J, Kniffin W, Malenka D, Mayor M, Keller RB (1996): Basic epidemiology of fractures of the upper and lower limb for Americans over 65 years of age. Epidemiology 7:612-618.
3. Beresford JN, Joyner CJ, Delvin C, Triffitt JT (1994): The effects of dexamethasone and 1,25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in vitro. Arch Oral Biol 39:941-947.
4. Bergman RJ, Gazit D, Kahn A, Gruber H, Dougal S, Hahn TJ (1996): Age-related changes in osteogenic stem cells in mice. J Bone Miner Res 11: 568-577.
5. Bolander ME (1992): Regulation of fracture repair by growth factors. Proc Soc Exp Biol Med 200:165-170.
6. Bonewald LF, Dallas SL (1994): Role of active and latent transforming growth factor β in bone formation. J Cell Biochem 55: 350-357.
7. Boonen S, Aerssens J, Dequeker J, Nicholson P, Cheng X, Lowet G, Verbeke G, Bouillon R (1997): Age-associated decline in human femoral neck cortical and trabecular content of insulin-like growth factor I: Potential implications for age-related (type II) osteoporotic fracture occurence. Calcif Tissue Int 61:173-178.
8. Bradford MM (1976): A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
9. Bruder SC, Jaiswal N, Haynesworth SE (1997): Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biol 64: 278-294.
10. Centrella M, Horowitz MC, Wozney JM, McCarthy TL (1994): Transforming Growth factor-β gene family members and bone. Endocrinol Rev 15:27-39.
11. Cheng S, Yang JW, Rifas L, Zhang S, Avioli LV (1994):. Differentiation of human bone marrow osteogenic stromal cell in vitro: Induction of osteoblast phenotype by dexamethasone. Endocrinology 134: 277-286.
12. Dallas SL, Miyazono K, Skerry TM, Mundy GR, Bonewald LF (1995): Dual role for the latent transforming growth factor beta binding protein (LTBP) in storage of latent TGF-β in the extracellular matrix and as a structural matrix protein. J Cell Biol 131: 539-549.
13. Dirschl DR, Henderson RC, Oakley WC (1997): Accelerated bone mineral loss following hip fracture: a prospective longitudinal study. Bone 21: 79-82.
14. Dunstan CR, Carrett IR, Adams R, Burgess W, Jaye M, Youngs T, Boyce R, Mundy GR (1995): Systemic fibroblast growth factor (FGF-1) prevents bone loss, increases new bone formation, and restores trabecular microarchitecture in ovariectomized rats. J Bone Miner Res 10: S198.
15. Eastell R, Delmas PD, Hosdgson SF, Erikson EF, Mann KG, Riggs BL (1988): Bone formation rate in older normal woman: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers. J Clin Endocrinol Metab 67: 741-748.
16. Erlebacher A, Filvaroff EH, Gitelman SE, Derynck R (1995): Towards a molecular understanding of skeletal development. Cell 80: 371-378.
17. Erlebacher A, Derynck R (1996): Increased Expression of TGF-β2 in osteoblast results in an osteoporosis-like phenotype. J Cell Biol 132: 195-210.
18. Friedenstein AJ, Petrakova KV, Kuralesova AI, Frolova GP (1968): Heterotopic transplants of bone marrow: Analysis of precursor cells for osteogenic and hemopoietic tissues. Transplantation 6: 230-240.
19. Friedenstein AJ (1976): Precursor cells of mechanocytes. Int Rev Cytol 47: 327-355.
20. Friedenstein AJ, Chailakhyan RK, Latzinik NV, Panasynk AF, Kelilis-Borok IV (1974): Stromal cells responsible for transferring the micronenvironment of hemopoietic tissues: Cloning in-vitro and retransplantation in-vivo. Transplantation 17: 331-340.
21. Finkelman RD, Bell NH, Strong DD, Demers LM, Baylink DJ (1992): Ovariectomy selectively reduces the concentration of transforming growth factor β in rat bone: Implications for estrogen deficiency-associated bone loss. Proc Natl Acad Sci USA 98: 12190-12193.
22. Gazit D, Ebner R, Kahn A, Derynck R (1993): Modulation of expression and cell surface binding of members of the TGF-β superfamily during retinoic acid-induced osteoblastic differentiation of multipotential mesenchymal cells. Mol Endo 7:189-198.
23. Hock JM, Canalis E, Centrella M (1990): Transforming growth factor-β stimulates bone matrix apposition and bone cell replication in cultured fetal rat calvariae. Endocrinology 126: 421-426.
24. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy B, Boyce BF (1996): Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β. Nature Med 2:1132-1136.
25. Inoue K, Ohgushi H, Yoshikawa T, Okumura M, Sempuku T, Tamai S, Dohi Y (1997): The effects of aging on bone formation in porous hydroxyapatite: Biochemical and histological analysis. J Bone Miner Res 12:989-994.
26. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP (1997): Osteogenic differentiation of purified culture-expanded human mesenchymal stem cells in vitro. J Cell Biol 64: 295-312.
27. Jennings J, Mohan C, Linkhart S, Widstrom TA, Baylink D (1988): Comparison of the biological actions of TGF beta-1 and TGF beta-2: Differential activity in endothelial cells. J Cell Physiol 137:167-172.
28. Johnson Jr. CC, Slemenda CW (1995): Pathogenesis of osteoporosis. Bone 17:19S-22S.
29. Joyce ME, Roberts AB, Sporn MB, Bolander ME (1990): Transforming growth factor-β and the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol 110:2195-2207.
30. Kahn A, Gibbons R, Perkins S, Gazit D (1995): Age- related bone loss: A hypothesis and initial assessment in mice. Clin Orthop 313: 69-75.
31. Kanis JA, Adami S (1994): Bone loss in the elderly. Osteoporosis Int. Supplement 1:S59-S59.
32. Krebsbach PH, Kuznetsov SA, Satomura K, Emmons RVB, Rowe DW, P. Gehron Robey PG (1997): Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 63:1059-1069.
33. Lawrence DA, Pircher R, Jullien P (1985): Conversion of a high molecular weight latent TGF-β from chicken embryo fibroblast into a low molecular weight active TGF-β under acidic conditions. Biochem Biophys Res Comm 133:1026-1034.
34. Leboy PS, Beresford JN, Devlin C, Owen ME (1991): Dexamethasone induction of osteoblasts mRNAs in rat marrow stromal cell cultures. J Cell Physiol 147: 111-120.
35. Manolagas SC, Jilka RL (1995): Bone marrow, cytokines and bone remodeling. N Engl J Med 322:305-320.
36. Manolagas SC, Jilka RL (1995): Bone marrow, cytokines, and bone remodeling. Emerging insights into pathophysiology of osteoporosis. N Engl J Med 332: 305-311.
37. Nicolas V, Prewett A, Bettica P, Mohan S, Finkelman RD, Baylink DJ, Farley JR (1994): Age-related decreases in insulin-like growth factor-I and transforming growth factor-b in femoral cortical bone from both men and women: Implications for bone loss with aging. J Clin Endocrinol Metab 78:1011-1016.
38. Nicolas V, Mohan S, Honda Y, Prewett A, Finkelman RD, Baylink DJ, Farley JR (1995): An age-related decrease in the concentration of insulin-like growth factor binding protein-5 in human cortical bone. Calcif Tissue Int 57:206-212.
39. Nordin BE, Need AG, Bridges A, Horowitz M (1992): Relative contributions of years since menopause, age, and weight to vertebral density in post menopausal women. J Clin Endocrinol Metab 74: 20-23.
40. Owen M (1988): Marrow stromal stem cells. J Cell Sci 10: 61-76.
41. Owen M, Friendenstein AJ (1988): Stromal stem cells: Marrow derived osteogenic precursors. Ciba Found Symposium 136: 42-53.
42. Parfitt AM, Villanueva AR, Foldes J, Sudhaker Rao D (1995): Relations between histologic indices of bone formation: Implications for the pathogenesis of spinal osteoporosis. J Bone Miner Res 10:466-473.
43. Prockop DJ (1997): Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276: 71-74.
44. Quarto R, Thomas D, Liang CT (1995): Bone progenitor cell deficits and the age-associated decline in bone repair capacity. Calcif Tissue Int 56:123-129.
45. Rickard DJ, Sullivan TA, Shenker BJ, Leboy PS, Kazhdan I (1994): Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 161: 218-228.
46. Roberts AB, Flanders DC, Kondiah P, Thompson NL, Van Obberghen-Schilling E, Wakefield L, Rossi P, de Crombrugghe B, Heine U, Sporn MB (1988): Transforming growth factor-β: Biochemistry and roles in embryogenesis, tissue repair, remodeling, and carcinogenesis. Recent Prog Horm Res 44:157-197.
47. Roholl PJK, Blauw E, Zurcher C, Dormans JAMA, Theuns HM (1994): Evidence for the diminished maturation of preosteoblasts into osteoblasts during aging in rats: An ultrastructural analysis. J Bone Miner Res 9: 355-366.
48. Rosen D, Miller C, DeLeon E, Thompson AY, Bentz H, Mathew M, Adams S (1994): Systemic administration of recombinant Transforming Growth Factor Beta (rTGF-β2) stimulates parameters of cancellous bone formation in juvenile and adult rats. Bone 15: 355-359.
49. Siegel S (1956): "Non Parametric Statistics for the Behavioral Sciences." New York: McGraw-Hill, pp 271-277.
50. Simmons DJ (1996): The in vivo Role of bone marrow fibroblast-like stromal cells. Calcif Tissue Int 58: 129-132.
51. Tsuji T, Hughes FJ, McCulloch CAG, Melcher AH (1990): Effects of donor age on osteogenic cells of rat bone marrow in vitro. Mech Aging Dev 51: 121-132.
52. Van Vlasselaer P, Borremans B, Van Gorp U, Dash JR, Waal-Malefjt R (1994): Interleukin 10 inhibits transforming growth factor-β synthesis required for osteogenic commitment of mouse bone marrow cells. J Cell Biol. 124:569-577.
53. Wang XF, Lin HY, Ng-Eaton E, Downward J, Lodish HF, Weinberg RA(1991): Expression cloning and characterization of the TGF-β type III receptor. Cell 67: 797-805.
54. Zeng G, McCue HM, Mastrangelo L, Millis AJT (1996): Endogenous TGF-β activity is modified during cellular aging: Effects on metalloproteinase and TIMP-1 expression. Exp Cell Res 228: 271-276.
55. Zhang RW, Supowit SC, Xu X, Li H, Christensen MD, Lozano R, Simmons DJ (1995): Expression of selected Osteogenic markers in the fibroblast-like cells of rat marrow stroma. Calcif Tissue Int 56: 283-291.